Mastodawn

A highly effective clinical protocol that combines the #immunotherapy atezolizumab (Tecentriq®) with standard adjuvant FOLFOX chemotherapy to treat patients with resected stage III #colon #cancer exhibiting deficient DNA mismatch repair (dMMR).
#Oncology #Immunology #sflorg
https://www.sflorg.com/2026/03/ongy03272601.html

Immunotherapy significantly improves outcomes for colon cancer

Results from the pivotal Phase III Alliance ATOMIC A021502 trial

Sonya Lopez 2d ago

Think immunotherapy is just "Chemo Lite"? Think again. 🧬 From how long it stays in your system to why it only works for some, we’re busting the 7 biggest myths about the new frontier of cancer treatment.

Read the 7 facts every patient should know: https://hashnode.com/edit/cmn7k9dkj01ur2dmm0lu0eiy8

: #CancerFacts #MedicalTransparency #HealthTips #Immunotherapy #CancerKillerCells

Hashnode

Hashnode is a blogging platform where developers, engineers, and tech leaders write to sharpen ideas, share knowledge, and build their reputation. Start for free.

Hashnode

David Ojcius Mar 21

Leveraging intratumoral probiotics for pancreatic cancer #immunotherapy via xenophagy.

#probiotic #microbiology #immunology

https://www.cell.com/cell-host-microbe/abstract/S1931-3128(26)00078-8

David Usharauli Mar 19

Catch-bond interactions are not easy to grasp compared to affinity and specificity. How are they measured, and is the approach reproducible?

#science
#immunology
#tumors
#immunotherapy

https://www.science.org/doi/10.1126/science.adx3162

GastroAGI Mar 19

🎯 HCC treatment is evolving…
TACE + immunotherapy + targeted therapy shows stronger outcomes—but are we ready to change practice?

⚠️ Promising data, but guidelines still need phase III confirmation

#GastroAGI #HCC #LiverCancer #TACE #Immunotherapy #TargetedTherapy #Hepatology #Oncology #MedEd

Show thread

Hans-Cees 🌳🌳🤢🦋🐈🐈🍋🍋🐝🐜Mar 19

@xs4me2 Wetenschappers laten deze week zien dat de gezondheid van dit orgaan, ook wel thymus genoemd, verband houdt met levensduur, veroudering, risico op hart- en vaatziekten en kanker

Echte ontdekkings wetenschap waarbij #ai nuttig is ingezet bij een deel van de studie
#kanker #Immunotherapy

neat_news Mar 18

In a small study with 12 patients using immunotherapy with a new antibody injected directly into tumors meant for 6 patients that their tumors shrank and for 2 that they went in complete remission. See http://www.neat-news.com/3551.php. #cancer #immunotherapy

Neat News

Neat News - Daily (not weekends) news about some positive development or insight.

Orbit News Hub Mar 16

MIIP Protein Blocks Colorectal Cancer Via Control of Immune Response

https://orbitnewshub.com/miip-protein-blocks-colorectal-cancer-via-control-of-immune-response/

#ColorectalCancer #MedicalResearch #Immunotherapy #OrbitNewsHub #HealthNews #CancerResearch

halama_immuno Mar 12

New publication on the role of #macrophages in shaping the tumor #microenvironment in #cancer ... leading to the exploration of #adipose tissue and it's impact on #innateimmunity and #adaptiveimmunity in #ovariancancer to the point where resistancr to #immunotherapy is observed. These findings are then put into action for patient stratification, showing the utility in #radiology and #medicaloncology and #oncology #Science #medicine #immunology

https://www.nature.com/articles/s41392-026-02594-8

Howard Smith MD, AM Mar 10

Laser-Aided Immunotherapy For Brain Cancer. Adding a laser procedure dramatically improves the results of immunotherapy for one of the deadliest brain cancers. #laser #immunotherapy #astrocytoma #cancer
https://www.instagram.com/p/DVt_oDBiVAO/

Howard G. Smith MD, AM on Instagram: "Laser-Aided Immunotherapy For Brain Cancer Adding a laser procedure dramatically improves the results of immunotherapy for one of the deadliest brain cancers. Neuro-oncologists at USC report this development in the journal Nature Communications. In this Phase 1/2 clinical trial, 45 patients with recurrent astrocytoma were randomized to receive either laser interstitial thermal therapy (LITT) that destroys tumor tissue and opens the blood-brain barrier plus the immunotherapy with the drug pembrolizumab immunotherapy or standard care, surgery, followed by the immunotherapy. The results are striking: nearly 50% of patients in the LITT group were alive at 18 months, compared with 0% in the standard-treatment group. In addition, more than one-third of LITT-treated patients survived beyond three years, compared to a typical 4–5 month survival seen with surgery and immunotherapy. The addition of of LITT, adding laser therapy to immunotherapy, is a potential game-changing approach. These results are early and require confirmation in larger trials, they offer real hope in a disease with limited therapeutic options and generally poor outcomes. https://doi.org/10.1038/s41467-026-69522-w https://www.news-medical.net/news/20260226/Innovative-laser-procedure-offers-new-hope-for-recurrent-brain-tumors.aspx #laser #immunotherapy #astrocytoma #cancer"

0 likes, 0 comments - drhowardsmithreports on March 10, 2026: "Laser-Aided Immunotherapy For Brain Cancer Adding a laser procedure dramatically improves the results of immunotherapy for one of the deadliest brain cancers. Neuro-oncologists at USC report this development in the journal Nature Communications. In this Phase 1/2 clinical trial, 45 patients with recurrent astrocytoma were randomized to receive either laser interstitial thermal therapy (LITT) that destroys tumor tissue and opens the blood-brain barrier plus the immunotherapy with the drug pembrolizumab immunotherapy or standard care, surgery, followed by the immunotherapy. The results are striking: nearly 50% of patients in the LITT group were alive at 18 months, compared with 0% in the standard-treatment group. In addition, more than one-third of LITT-treated patients survived beyond three years, compared to a typical 4–5 month survival seen with surgery and immunotherapy. The addition of of LITT, adding laser therapy to immunotherapy, is a potential game-changing approach. These results are early and require confirmation in larger trials, they offer real hope in a disease with limited therapeutic options and generally poor outcomes. https://doi.org/10.1038/s41467-026-69522-w https://www.news-medical.net/news/20260226/Innovative-laser-procedure-offers-new-hope-for-recurrent-brain-tumors.aspx #laser #immunotherapy #astrocytoma #cancer".

Instagram